Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES)

Metallomics

Volumn 4, Issue 6, 2012, Pages 568-575

  Hall, Matthew D ^a,d   Daly, Helen L ^a   Zhang, Jenny Z ^a   Zhang, Mei ^b   Alderden, Rebecca A ^a   Pursche, Daniel ^a   Foran, Garry J ^c   Hambley, Trevor W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c AUSTRALIAN SYNCHROTRON   (Australia)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIAL LIGAND; CARBOPLATIN; CIS-PLATIN; COMPLEX BIOLOGICAL SYSTEMS; DRUG CANDIDATES; GROWTH MEDIA; KINETIC INERTNESS; OVARIAN CANCER CELLS; OXALIPLATIN; OXIDATION STATE; PT COMPLEXES; QUANTITATIVE MEASUREMENT; REDUCTION POTENTIAL; TRANSPLATIN; WHITE LINES; X-RAY ABSORPTION NEAR EDGE SPECTROSCOPY; X-RAY ABSORPTION NEAR-EDGE SPECTRUM; XANES;

CYTOTOXICITY; PLATINUM; X RAY ABSORPTION;

PLATINUM COMPOUNDS;

CISPLATIN; PLATINUM COMPLEX; TRANSPLATIN; ANTINEOPLASTIC AGENT; CARBOPLATIN; OXALIPLATIN;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; OVARY CANCER; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; X RAY ABSORPTION NEAR EDGE SPECTROSCOPY; X RAY ABSORPTION SPECTROSCOPY; CELL SURVIVAL; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; METHODOLOGY; OXIDATION REDUCTION REACTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; CULTURE MEDIA; HUMANS; ORGANOPLATINUM COMPOUNDS; OXIDATION-REDUCTION; X-RAY ABSORPTION SPECTROSCOPY;

EID: 84866437928     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c2mt20053h     Document Type: Article

References (37)

1. M. D. Hall, H. R. Mellor, R. Callaghan and T. W. Hambley, J. Med. Chem., 2007, 50, 3403-3411.
2. L. Kelland, Nat. Rev. Cancer, 2007, 7, 573-584.
3. M. D. Hall and T. W. Hambley, Coord. Chem. Rev., 2002, 232, 49-67.
4. M. D. Hall, R. C. Dolman and T. W. Hambley, Met. Ions Biol. Syst., 2004, 42, 297-322.
5. L. Pendyala, W. Greco, J. W. Cowens, S. Madajewicz and P. J. Creaven, Cancer Chemother. Pharmacol., 1983, 11, 23-28.
6. W. P. Petros, S. G. Chaney, D. C. Smith, J. Fangmeier, M. Sakata, T. D. Brown and D. L. Trump, Cancer Chemother. Pharmacol., 1994, 33, 347-354.
7. C. T. Dillon, P. A. Lay, M. Cholewa, G. J. F. Legge, A. M. Bonin, T. J. Collins, K. L. Kostka and G. Shea-McCarthy, Chem. Res. Toxicol., 1997, 10, 533-535.
8. P. Frank, R. M. Carlson, E. J. Carlson and K. O. Hodgson, J. Inorg. Biochem., 2003, 94, 59-71.
9. J. G. Parsons, M. V. Aldrich and J. L. Gardea-Torresdey, Appl. Spectrosc. Rev., 2002, 37, 187-222.
10. P. D. Bonnitcha, M. D. Hall, C. K. Underwood, G. J. Foran, M. Zhang, P. J. Beale and T. W. Hambley, J. Inorg. Biochem., 2006, 100, 963-971.
11. R. C. Elder and M. K. Eidsness, Chem. Rev., 1987, 87, 1027-1046.
12. M. D. Hall, G. J. Foran, M. Zhang, P. J. Beale and T. W. Hambley, J. Am. Chem. Soc, 2003, 125, 7524-7525.
13. A. Nemirovski, I. Vinograd, K. Takrouri, A. Mijovilovich, A. Rompel and D. Gibson, Chem. Commun., 2010, 46, 1842-1844.
14. H. L. Daly, M. D. Hall, T. W. Failes, M. Zhang, G. J. Foran and T. W. Hambley, Aust. J. Chem., 2011, 64, 273-278.
15. F. W. Lytle, P. S. P. Wei, R. B. Greegor, G. H. Via and J. H. Sinfelt, J. Chem. Phys., 1979, 70, 4849-4855.
16. C. J. Boreham, J. A. Broomhead and D. P. Fairlie, Aust. J. Client., 1981, 34, 659-664.
17. S. C. Dhara, Indian J. Chem., 1970, 8, 193-194.
18. J. D. Hoeschele, T. A. Butler, J. A. Roberts and C. E. Guyer, Radiochim. Acta, 1982, 31, 27-36.
19. M. D. Hall, S. Amjadi, M. Zhang, P. J. Beale and T. W. Hambley, J. Inorg. Biochem., 2004, 98, 1614-1624.
20. G. B. Kauffman, Inorg. Synth., 1963, 7, 236-238.
21. I. Mochida, J. A. Mattern and J. C. Bailar, J. Am. Chem. Soc, 1975, 97, 3021-3026.
22. J. L. van der Veer, G. J. Ligtvoet and J. Reedijk, J. Inorg. Biochem., 1987, 29, 217-223.
23. R. J. Brandon and J. C. Dabrowiak, J. Med. Chem., 1984, 27, 861-865.
24. L. T. Ellis, H. M. Er and T. W. Hambley, Aust. J. Chem., 1995, 48, 793-806.
25. G. B. Kauffman and R. J. Thompson, Inorg. Synth., 1963, 7, 248-253.
26. N. S. Kurnakow, J. Prakt. Chem., 1894, 50, 483.
27. D. P. Mellor, Chem. Rev., 1943, 33, 137-183.
28. B. C. Behrens, T. C. Hamilton, H. Masuda, K. R. Grotzinger, J. Whang-Peng, K. G. Louie, T. Knutsen, W. M. McKoy, R. C. Young and R. F. Ozols, Cancer Res., 1987, 47, 414-418.
29. J. Holford, P. J. Beale, F. E. Boxall, S. Y. Sharp and L. R. Keiiand, Eur. J. Cancer, 2000, 36, 1984-1990.
30. J. Carmichael, W. G. DeGraff, A. F. Gazdar, J. D. Minna and J. B. Mitchell, Cancer Res., 1987, 47, 943-946.
31. T. W. Hambley, A. R. Battle, G. B. Deacon, E. T. Lawrenz, G. D. Fallon, B. M. Gatehouse, L. K. Webster and S. Rainone, J. Inorg. Biochem., 1999, 77, 3-12.
32. K. Lemma, T. Shi and L. I. Elding, Inorg. Chem., 2000, 39, 1728-1734.
33. R. Kuroda, S. Neidle, I. M. Ismail and P. J. Sadler, Inorg. Chem., 1983, 22, 3620-3624.
34. M. Brown, R. E. Peierls and E. A. Stern, Phys. Rev. B, 1977, 15.
35. F. W. Lytle, J. Catal., 1976, 43, 376-379.
36. M. S. Davies, M. D. Hall, S. J. Berners-Price and T. W. Hambley, Inorg. Chem., 2008, 47, 7673-7680.
37. R. C. Dolman, G. B. Deacon and T. W. Hambley, J. Inorg. Biochem., 2002, 88, 260-267.